- Companies
- Remgro
Remgro Valuation Multiples
Remgro is valued at $7.1B as of October 2026, a 2.0x revenue multiple. In the last fiscal year, Remgro revenue was $3.2B and Remgro EBITDA was $396M.
Remgro Overview
About Remgro
Remgro Ltd is an investment holding company with investments in the healthcare, consumer products, financial services, infrastructure, industrial, and media industries. Its segments include Consumer Products and Industrial and Other. It derives the majority of its revenue from Consumer Products.
Founded
1940
HQ
Employees
175
Website
Sectors
Financials (Last FY)
EV
$6.3B
Valuation Multiples
Start free trialRemgro Financials
Remgro reported last fiscal year revenue of $3.2B and EBITDA of $396M.
In the same fiscal year, Remgro generated $1B in gross profit, $396M in EBITDA, and $88M in net income.
Revenue (LTM)
Remgro P&L
In the most recent fiscal year, Remgro reported revenue of $3.2B and EBITDA of $396M.
Remgro is profitable as of last fiscal year, with gross margin of 32%, EBITDA margin of 12%, and net margin of 3%.
Financial data powered by Morningstar, Inc.
Remgro Stock Performance
Remgro has current market cap of $7.1B, and enterprise value of $6.3B.
Market Cap Evolution
Remgro's stock price is $12.81.
Remgro share price increased by 4.1% in the last 30 days, and by 28.8% in the last year.
Remgro has an EPS (earnings per share) of $0.16.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6.3B | $7.1B | 1.9% | 4.1% | 8.1% | 28.8% | $0.16 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRemgro Valuation Multiples
Remgro trades at 2.0x EV/Revenue multiple, and 15.9x EV/EBITDA.
EV / Revenue (LTM)
Remgro Financial Valuation Multiples
As of October 22, 2026, Remgro has market cap of $7.1B and EV of $6.3B.
Remgro has a P/E ratio of 10.2x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Remgro Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Remgro Margins & Growth Rates
In the most recent fiscal year, Remgro reported gross margin of 32%, EBITDA margin of 12%, and net margin of 3%.
Remgro Margins
Remgro Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Remgro Operational KPIs
Remgro's revenue per employee in the last FY averaged $18.4M, while opex per employee averaged $3.9M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Remgro Competitors
Remgro competitors include China Industrial Securities, Sprott Physical Gold, Jardine Cycle & Carriage, St James's Place, Infratil, Migdal Group, Intermediate Capital Group, TPG, FUNO and VZ VermögensZentrum.
Most Remgro public comparables operate across Asset Management.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $1.8B | - | 4.0x | 3.5x | - | - | |||
| $4.4B | - | 1.6x | - | - | - | |||
| $21B | $4.4B | 1.0x | 1.1x | 4.8x | 6.2x | |||
| $40B | $1.8B | - | - | - | - | |||
| $1.7B | $676M | 7.0x | 5.7x | 17.6x | 19.3x | |||
| $11B | $1.1B | - | - | - | - | |||
| $1.4B | $801M | 10.0x | 10.6x | 17.8x | 18.1x | |||
| $4.8B | $1.1B | 2.5x | 4.7x | 10.5x | 9.2x | |||
This data is available for Pro users. Sign up to see all Remgro competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by Remgro
Remgro has acquired 2 companies to date.
Last acquisition by Remgro was on March 30th 2026. Remgro acquired Mediclinic Southern Africa for $950M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Remgro
| Description | Mediclinic Southern Africa operates private hospitals for multi-disciplinary acute care. | Mediclinic is an international private hospital group headquartered in Stellenbosch, South Africa, with operations in South Africa, Namibia, Switzerland and the United Arab Emirates. It runs acute-care hospitals, day-case clinics and outpatient facilities, including the Hirslanden group in Switzerland and Mediclinic Middle East, and holds a 29.9% interest in the UK private healthcare group Spire Healthcare. The group earns revenue from inpatient and outpatient services paid by medical schemes, insurers and patients, and reported revenue of ÂŁ3,233 million in 2022, with more than 37,000 employees across 134 facilities in 2024. Mediclinic was founded in 1983 in Stellenbosch by Dr Edwin Hertzog, commissioned by the Rembrandt Group, now Remgro, and listed on the JSE in 1986. It bought Hirslanden in 2007 and, after a reverse merger with Al Noor Hospitals, began trading on the London Stock Exchange in February 2016. A consortium of Remgro and MSC Mediterranean Shipping Company took it private in 2023 after a ÂŁ3.7 billion offer announced in August 2022, and in April 2026 Remgro agreed to take full ownership of Mediclinic Southern Africa while Hirslanden is sold to IHL. |
| HQ Country | ||
| HQ City | Vereeniging | Stellenbosch |
| Deal Date | 30 Mar 2026 | 4 Aug 2022 |
| Valuation | $950M | $7.7B |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Remgro acquisitions and their M&A valuation multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Remgro
| When was Remgro founded? | Remgro was founded in 1940. |
| Where is Remgro headquartered? | Remgro is headquartered in South Africa. |
| How many employees does Remgro have? | As of today, Remgro has over 175 employees. |
| Who is the CEO of Remgro? | Remgro's CEO is Jannie Durand. |
| Is Remgro publicly listed? | Yes, Remgro is a public company listed on Johannesburg Stock Exchange. |
| What is the stock symbol of Remgro? | Remgro trades under REM ticker. |
| When did Remgro go public? | Remgro went public in 2000. |
| Who are competitors of Remgro? | Remgro main competitors include China Industrial Securities, Sprott Physical Gold, Jardine Cycle & Carriage, St James's Place, Infratil, Migdal Group, Intermediate Capital Group, TPG, FUNO, VZ VermögensZentrum. |
| What is the current market cap of Remgro? | Remgro's current market cap is $7.1B. |
| What is the current revenue of Remgro? | Remgro's last fiscal year revenue is $3.2B. |
| What is the current EV/Revenue multiple of Remgro? | Current revenue multiple of Remgro is 2.0x. |
| What is the current net income of Remgro? | Remgro's last 12 months net income is $702M. |
| How many companies Remgro has acquired to date? | As of October 2026, Remgro has acquired 2 companies. |
| What was the largest acquisition by Remgro? | $7.7B acquisition of Mediclinic International on 4th August 2022 was the largest M&A Remgro has done to date. |
| What companies Remgro acquired? | Remgro acquired Mediclinic International and Mediclinic Southern Africa. |
| In how many companies Remgro has invested to date? | Remgro hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Remgro
Lists including Remgro
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




